Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

7.44p
   
  • Change Today:
      0.28p
  • 52 Week High: 17.60
  • 52 Week Low: 1.50
  • Currency: UK Pounds
  • Shares Issued: 502.72m
  • Volume: 970,369
  • Market Cap: £37.40m
  • RiskGrade: 328
  • Beta: 1.16

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £110,742
Lisa Baderoon 583,963 £43,447
Tim Franklin 525,000 £39,060

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 25,108,044 £1,868,038
Invesco Ltd 17,872,341 £1,329,702
Aviva Investors Global 11,285,180 £839,617
Alora Pharmaceuticals LLC 10,909,091 £811,636
M&G Investments 7,600,000 £565,440
Prudential plc 7,600,000 £565,440
Capital Income Builder 4,870,367 £362,355
Dr R Zimmer 4,551,553 £338,636
Odey Asset Management 3,433,319 £255,439
Rhone Trustees (Switzerland) SA 3,386,000 £251,918
Pictet Overseas Trust Corporation Limited 3,287,500 £244,590

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 7.44p
Change Today 0.28p
% Change 3.91 %
52 Week High 17.60
52 Week Low 1.50
Volume 970,369
Shares Issued 502.72m
Market Cap £37.40m
Beta 1.16
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 15-Jan-2026

Time Volume / Share Price
10:33 1,454 @ 7.29p
10:31 2,543 @ 6.94p
10:30 30 @ 7.46p
10:29 25,124 @ 7.01p
10:23 15,000 @ 7.01p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page